What are the side effects of ibrutinib/ibrutinib?

Ibrutinib/Ibrutinib is a commonly used anti-cancer drug, mainly used to treat certain types of lymphoma and leukemia. However, like many other drugs, ibrutinib comes with a range of side effects. The severity of these side effects varies from person to person and depends on factors such as the patient's overall health, the dosage of the medication, and the length of treatment.

Common side effects of ibrutinib occur in more than30% of clinical patients, including bleeding complications caused by thrombocytopenia or changes in platelet function, diarrhea, neutropenia, hemoglobin reduction, fatigue, musculoskeletal pain, swelling, upper respiratory tract infection, nausea and ecchymosis, etc. These side effects may have a certain impact on the patient's daily life, but can usually be controlled and alleviated by adjusting drug dosage or taking other therapeutic measures.

In addition, there are some less common side effects, which occur in about10-30% of patients. These side effects include high blood pressure, shortness of breath, constipation, rash, abdominal pain, vomiting, loss of appetite, cough, fever, irritation of the mouth and lips, dizziness, urinary tract infection, pneumonia, skin infection, fatigue or weakness, muscle cramps, sinusitis, headache, dehydration, indigestion, petechiae (red or purple spots caused by bleeding capillaries), joint pain, and nose bleeds. Although these side effects are relatively rare, once they occur, they may have a certain impact on the patient's health.

It is worth noting that 5-10% of patients taking ibrutinib will develop heartbeat abnormalities, such as atrial fibrillation. This is a serious side effect and may cause damage to heart function. Therefore, patients should pay close attention to their heart condition while taking ibrutinib, and seek medical attention immediately if symptoms such as fast heartbeat, chest pain, dizziness, and hypotension occur.